**Clinical Trials Matching Software Market Size & Growth Analysis**
*Austin, Nov. 12, 2025 (GLOBE NEWSWIRE)* — According to SNS Insider, the global clinical trials matching software market was valued at USD 187.14 million in 2024 and is expected to reach USD 501.86 million by 2032. This growth reflects a compound annual growth rate (CAGR) of 13.14% from 2025 to 2032.
The U.S. segment, valued at USD 74.78 million in 2024, is projected to hit USD 199.51 million by 2032. This expansion is driven by advanced healthcare IT infrastructure, rising clinical trial volumes, and the increasing adoption of AI-enabled patient-matching applications.
Demand for high-precision patient matching is rising due to the increasing complexity of trials, tighter eligibility criteria, and the pressure on sponsors and contract research organizations (CROs) to accelerate enrollment and boost trial efficiency. Leading platforms now integrate electronic health records (EHRs), deploy real-time eligibility screening, and offer patient-facing channels that enhance outreach and diversity.
As the industry pivots toward decentralized trials, personalized matching and cloud-enabled workflow tools are becoming central to clinical trial operations.
—
### Key Market Players
Major players featured in the Clinical Trials Matching Software Market Report include:
– IBM Watson Health
– Antidote Technologies
– Deep 6 AI
– TriNetX
– Clinerion
– ConcertAI
– Emergent Connect
– Trialspark
– ClinOne
– Elligo Health Research
– Phreesia
– HealthMatch
– SubjectWell
– JPNV
– TrialJectory
– Parexel
– Inato
– Mendel.ai
– PatientWing
– Flatiron Health
—
### Market Segmentation Analysis
**By Mode**
– *Web & Cloud-based* led the market with a 90.94% share in 2024, owing to scalability, real-time accessibility, and seamless integration with EHRs.
– *On-premises* is the fastest-growing segment, growing at a CAGR of 14.32%. This growth is driven by increasing requirements for data security, regulatory standards, and organizational control over sensitive patient data.
**By Component**
– *Software/Platform* dominated with a 65.83% market share in 2024, serving as the core for computerized patient-trial matching, eligibility screening, and protocol feasibility.
– *Services* segment is expected to grow fastest at a CAGR of 13.44%, fueled by increasing demand for implementation, systems integration, and consulting services.
**By Application**
– *Patient Recruitment & Matching* led the market with a 45.34% share in 2024, thanks to capabilities in scalability and EHR integration.
– *Data Integration & Interoperability* recorded the fastest growth, with a CAGR of 13.48%, driven by the need to aggregate disparate healthcare data from EHRs, labs, and wearable devices.
**By End-User**
– *Pharmaceutical & Biotechnology Companies* held a commanding 60.86% share in 2024, driven by their high volume of clinical trials, significant R&D investments, and the imperative to accelerate patient recruitment.
– *CROs* are the fastest-growing end-user segment with a CAGR of 13.86%, supported by increased outsourcing of clinical operations by pharma and biotech companies.
—
### Regional Insights
In 2024, **North America** dominated the clinical trials matching software market, accounting for 48.60% of revenue share. This leadership is attributable to widespread healthcare IT penetration, a large concentration of clinical trials, and the presence of leading software vendors.
The **Asia Pacific** region is expected to witness the fastest growth over 2025-2032, with a projected CAGR of 13.94%. This growth is driven by an acceleration in clinical trial activities, expanding healthcare infrastructure, and strong government support for digital health initiatives.
—
### Recent Developments
– In March 2024, IBM Watson Health launched **Watson for Clinical Trials Enrollment 2.0**, enhancing AI-driven patient matching with EHR data, which has reduced recruitment times by 30% in oncology and cardiology trials.
– In July 2024, the company expanded into Europe and the Asia Pacific, integrating AI-powered patient engagement tools that have boosted decentralized trial enrollment, particularly in rare disease and oncology studies.
—
### Exclusive Report Sections (Unique Selling Points)
– **Software Adoption & AI Integration Metrics:** Analyze global and regional adoption rates of clinical trial matching platforms and understand how AI/ML-driven eligibility algorithms are transforming patient-trial pairing efficiency.
– **Patient Enrollment & Demographic Insights:** Explore enrollment patterns by age, condition, and geography, alongside success rate improvements across therapeutic areas enabled by digital trial matching tools.
– **Interoperability & Platform Integration Index:** Evaluate the connectivity level of EHR/EMR systems, API usage among CROs and sponsors, and integration of decentralized clinical trial (DCT)-ready features that enhance data fluidity and trial efficiency.
– **Sponsor & Site Utilization Benchmarks:** Compare software usage across pharma, biotech, CROs, and academic institutions while quantifying improvements in trial site performance and reduced time-to-enrollment.
– **Cost Efficiency & ROI Analytics:** Measure the economic value of trial matching software through metrics like per-patient cost savings, accelerated recruitment-driven revenue gains, and differences between SaaS and enterprise-level adoption models.
– **Technological Competitiveness Landscape:** Identify leading vendors based on adoption scale, platform innovation, and integration capabilities, revealing the strongest investment and growth opportunities in the evolving clinical trial ecosystem.
—
### Clinical Trials Matching Software Market Report Scope
| Report Attribute | Details |
|———————|————————————————————–|
| Market Size in 2024 | USD 187.14 million |
| Market Size by 2032 | USD 501.86 million |
| CAGR | 13.14% (2025 – 2032) |
| Base Year | 2024 |
| Forecast Period | 2025 – 2032 |
| Historical Data | 2021 – 2023 |
| Key Segments | By Mode (Web & Cloud-based, On-premises) |
| | By Component (Software/Platform, Services) |
| | By Application (Patient Recruitment & Matching, Protocol Feasibility & Site Selection, Real-time Patient Monitoring, Data Integration & Interoperability) |
| | By End User (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms) |
| Regional Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America) |
—
### Get the Complete Market Report
For more information or to request customized research on the Clinical Trials Matching Software Market, please contact us at:
**Email:** info@snsinsider.com
—
### About SNS Insider
SNS Insider is a leading global market research and consulting agency. Our mission is to empower clients with the knowledge required to thrive in changing environments. Utilizing various methodologies including surveys, video discussions, and focus groups worldwide, we deliver current, precise market data, consumer insights, and expert opinions to support confident decision-making.
—
*Source: SNS Insider – Comprehensive Clinical Trials Matching Software Market Report*
https://www.globenewswire.com/news-release/2025/11/12/3186236/0/en/Clinical-Trials-Matching-Software-Market-Size-to-Reach-USD-501-86-Million-by-2032-Driven-by-AI-and-EHR-Integration-SNS-Insider.html